ILOSONE
LOE ApproachingNDAORALSUSPENSION
Approved
Apr 1967
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 5h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ILOSONE is an oral suspension small-molecule antibiotic approved in 1967 by Eli Lilly. The generic name and specific mechanism of action are not disclosed in available data, but the product is indicated for bacterial infections treatable via oral administration. This is a legacy product nearing loss of exclusivity.
LOE Approaching
As a legacy product approaching LOE with moderate competitive pressure (30), the commercial team is likely in maintenance mode with minimal growth opportunity and smaller dedicated headcount.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
With zero linked job postings and LOE approaching, ILOSONE offers minimal career development opportunity and is unlikely to be a growth platform for advancement. Assignment to this product typically signals a maintenance or transition role within a larger portfolio, best suited for professionals seeking stability rather than rapid career progression.
Brand ManagerField Sales Representative
Worked on ILOSONE at Eli Lilly and Company? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.